Linagliptin demonstrates cardiovascular and renal safety in Asian adults with type 2 diabetes
In a sub-analysis of the CAROLINA cardiovascular outcome trial, linagliptin demonstrated no increased cardiovascular risk versus…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.